Trial intelligence / Profile preview

Comparison of Asparaginase Forms in Relapsed/Refractory ALL

NCT00187083Phase 3Completed

Sponsor
St. Jude Children's Research Hospital
Start
Feb 1997
Primary completion
Dec 2003
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by St. Jude Children's Research Hospital. Started Feb 1997; status: completed.

02

Drugs

pegaspargase
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT00187083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00187083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call